NCT06762119 A Study of CAR-T Cells in Subjects with Autoimmune Diseases Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06757426 Prospective Observational Study Evaluating the Safety and Efficacy of Immunomodulatory Therapies in Refractory Inflammatory and Autoimmune Diseases Status NOT_YET_RECRUITING Phase N/A
NCT06747156 A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases Status RECRUITING Phase EARLY_PHASE1
NCT06736587 A Randomized, Double-blind, Placebo-controlled, Dose-escalation Phase 1 Clinical Tiral in Healthy Male Volunteers Status RECRUITING Phase PHASE1
NCT06723548 Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis Status NOT_YET_RECRUITING Phase PHASE4
NCT06688799 Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases Status RECRUITING Phase PHASE1/PHASE2
NCT06680388 CD19 CAR-T in the Treatment of Relapsed/Refractory Autoimmune Diseases Status RECRUITING Phase EARLY_PHASE1
NCT06677710 IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis Status SUSPENDED Phase PHASE1
NCT06670274 A Dose Escalating Study of HC002 in Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT06626919 A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases Status RECRUITING Phase PHASE1
NCT06587828 A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease Status RECRUITING Phase N/A
NCT06575426 A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus Status RECRUITING Phase PHASE1/PHASE2
NCT06567080 JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases Status NOT_YET_RECRUITING Phase PHASE1
NCT06549296 Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases Status SUSPENDED Phase EARLY_PHASE1
NCT06548607 Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases Status RECRUITING Phase EARLY_PHASE1
NCT06534177 Digital Diagnostics and Intervention Services for Parkinson's Disease Status NOT_YET_RECRUITING Phase N/A
NCT06507800 Cancer as a complicATion in reCipients of Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Disease iNdiCation trEated in FRance and Canada? Status NOT_YET_RECRUITING Phase N/A
NCT06503224 An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases Status RECRUITING Phase NA